NDC codes

412572 NDC codes with hospital pricing data in the network.

• NDC 00409-1894-01 — INJECTION, MORPHINE SULFATE, UP TO 10 MG (2 hospitals, 102–147 samples)
• NDC 10135-0774-01 — PREDNISONE 1 MG TAB 100 EACH BLIST PACK (7 hospitals, 93–147 samples)
• NDC 00310-4505-25 — TREMELIMUMAB-ACTL 25 MG/1.25ML IV SOLN (362 hospitals, 39–147 samples)
• NDC 72485-0106-25 — Levetiracetam 500 mg/5 mL IV solutionAI (94 hospitals, 129–147 samples)
• NDC 990711509 — Potassium chloride in sodium chloride IV solutionAI (65 hospitals, 66–147 samples)
• NDC 8913020201 — Durolane hyaluronic acid knee injectionAI (29 hospitals, 111–147 samples)
• NDC 591213657 — Propofol intravenous emulsionAI (10 hospitals, 102–147 samples)
• NDC 1698602080 — HYALURONATE SODIUM, STABILIZED 60 MG/3 ML IATC SYRG [170125] (4 hospitals, 111–147 samples)
• NDC 93939-9393-93 — LIDOCAINE BUFFERED : 20ML [CMH] (1 hospital, 48–147 samples)
• NDC 00781-3341-09 — Levofloxacin injectionAI (28 hospitals, 29–146 samples)
• NDC 24979-0710-51 — PACLITAXEL PROTEIN-BOUND 100 MG INTRAVENOUS SUSPENSIONAI (129 hospitals, 38–146 samples)
• NDC 63323-0650-10 — Oxaliplatin 50 mg/10 mL intravenous solutionAI (34 hospitals, 56–146 samples)
• NDC 591544301 — Prednisone 20 mg tabletAI (68 hospitals, 137–146 samples)
• NDC 603533921 — Prednisone 20 mg tabletsAI (42 hospitals, 137–146 samples)
• NDC 50458-0166-01 — Levofloxacin 750 mg premixed in dextrose solutionAI (85 hospitals, 29–146 samples)
• NDC 89141-0456-02 — Oral wound care gel packetAI (67 hospitals, 74–146 samples)
• NDC 00069-4494-02 — Elranatamab injection 40 mg/mL solutionAI (225 hospitals, 119–146 samples)
• NDC 63323-0376-41 — Octreotide acetate 100 mcg/mL injectionAI (108 hospitals, 56–146 samples)
• NDC 70092-1130-36 — Morphine sulfate in saline bag, 100 mLAI (138 hospitals, 29–146 samples)
• NDC 62332-0607-25 — Glycopyrrolate 0.2 mg/mL injectionAI (24 hospitals, 83–146 samples)
• NDC 62332-0607-01 — Glycopyrrolate (10 hospitals, 83–146 samples)
• NDC 63323085225B — HYDROMORPHONE PCA 10MG/50ML (1 hospital, 56–146 samples)
• NDC 83634-0451-10 — Desmopressin injection, 4 mcg/mLAI (212 hospitals, 28–145 samples)
• NDC 14789-0107-05 — Potassium chloride injection 20 mEq per 50 mLAI (73 hospitals, 64–145 samples)
• NDC 409339004 — Piperacillin-tazobactam 4.5 gram IV solutionAI (76 hospitals, 46–145 samples)
• NDC 74501501 — Risankizumab injection 60 mg/mL, 10 mL vialAI (154 hospitals, 28–145 samples)
• NDC 61703-0319-22 — Cytarabine preservative-free injection solutionAI (615 hospitals, 27–144 samples)
• NDC 50383-0792-16 — Valproic acid oral syrupAI (80 hospitals, 117–144 samples)
• NDC 66658-0230-01 — Palivizumab injection 50 mgAI (321 hospitals, 144 samples)
• NDC 00904-4181-60 — Vitamin B complex tabletsAI (72 hospitals, 117–144 samples)
• NDC 00904-7239-61 — Sodium chloride 1,000 mg tabletAI (257 hospitals, 45–144 samples)
• NDC 70436-0120-80 — Leucovorin injection, 500 mg vialAI (100 hospitals, 81–144 samples)
• NDC 00002-1037-02 — PHENobarbital 60 mg Tab (2 hospitals, 117–144 samples)
• NDC 00004-6314-01 — naproxen 375 mg Tab (2 hospitals, 117–144 samples)
• NDC 00034-2100-87 — povidone iodine 10% Top Soln 480 mL (2 hospitals, 117–144 samples)
• NDC 00052-0107-30 — mirtazapine 30 mg Tab (9 hospitals, 117–144 samples)
• NDC 00093-7248-06 — Lamotrigine 200 mg tablets, 60-count bottleAI (15 hospitals, 117–144 samples)
• NDC 00574-0120-04 — Activated charcoal with sorbitol liquidAI (38 hospitals, 117–144 samples)
• NDC 17856-0012-01 — Multivitamin Oral Soln 15mL (7 hospitals, 117–144 samples)
• NDC 50580-0184-01 — Ibuprofen 100mg/5mL Oral Liq 5mL (4 hospitals, 117–144 samples)
• NDC 338002303 — Dextrose 10% solution, 500 mL bagAI (145 hospitals, 63–144 samples)
• NDC 00143-9428-01 — Fosaprepitant 150 mg IV injectionAI (115 hospitals, 81–144 samples)
• NDC 17460-0000-00 — METOCLOPRAMIDE 5MG/ML 2ML (1 hospital, 99–144 samples)
• NDC 270014957 — Diatrizoate meglumine 30% oral solution, 300 mL bottleAI (121 hospitals, 36–144 samples)
• NDC 409710066 — Dextrose 5% in water IV bagAI (46 hospitals, 63–144 samples)
• NDC 0003218710 — Abatacept intravenous infusion, 250 mgAI (21 hospitals, 27–144 samples)
• NDC 0003218713 — Abatacept 250 mg intravenous solutionAI (65 hospitals, 27–144 samples)
• NDC 0003218851 — ABATACEPT 125 MG/ML SUBCUTANEOUS AUTO-INJECTORAI (20 hospitals, 27–144 samples)
• NDC 409710067 — Dextrose 5% in water IV piggybackAI (43 hospitals, 63–144 samples)
• NDC 71288-0139-51 — Mitomycin 40 mg intravenous injectionAI (147 hospitals, 36–144 samples)